Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (981-990 of 1,467) with videos related to

Pageof 147
Sort By:
Nanoscale|January 10, 2015
Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infectionsFuwu Zhang, Justin A Smolen, Shiyi Zhang, et al.
Nanoscale|October 17, 2017
Design and development of multifunctional polyphosphoester-based nanoparticles for ultrahigh paclitaxel dual loadingFuwu Zhang, Sarosh Khan, Richen Li, et al.
Circulation|January 7, 2016
Relation of Nailfold Capillaries and Autoantibodies to Mortality in Patients With Raynaud PhenomenonMarkus Mueller, Michael E Gschwandtner, Jutta Gamper, et al.
International Journal of Radiation Oncology, Biology, Physics|November 10, 2023
Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic ReviewSierra Silverwood, Katie Lichter, Alexandra Conway, et al.
Arthritis and Rheumatism|July 9, 2003
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic miceGeorg Schett, Kurt Redlich, Silvia Hayer, et al.
Annals of the Rheumatic Diseases|June 1, 1987
HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigensJ S Smolen, J H Klippel, E Penner, et al.
Neurobiology of Aging|May 26, 2019
APOE effects on cognition from childhood to adolescenceChandra A Reynolds, Andrew Smolen, Robin P Corley, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
The Journal of Rheumatology|October 17, 2007
Association of anemia and physical disability among patients with rheumatoid arthritisChenglong Han, Mahboob U Rahman, Mittie K Doyle, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trialsM Boers, P Tugwell, D T Felson, et al.
Pageof 147

Showing results (981-990 of 1,467) with videos related to

Sort By:
Pageof 147
Nanoscale|January 10, 2015
Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infectionsFuwu Zhang, Justin A Smolen, Shiyi Zhang, et al.
Nanoscale|October 17, 2017
Design and development of multifunctional polyphosphoester-based nanoparticles for ultrahigh paclitaxel dual loadingFuwu Zhang, Sarosh Khan, Richen Li, et al.
Circulation|January 7, 2016
Relation of Nailfold Capillaries and Autoantibodies to Mortality in Patients With Raynaud PhenomenonMarkus Mueller, Michael E Gschwandtner, Jutta Gamper, et al.
International Journal of Radiation Oncology, Biology, Physics|November 10, 2023
Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic ReviewSierra Silverwood, Katie Lichter, Alexandra Conway, et al.
Arthritis and Rheumatism|July 9, 2003
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic miceGeorg Schett, Kurt Redlich, Silvia Hayer, et al.
Annals of the Rheumatic Diseases|June 1, 1987
HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigensJ S Smolen, J H Klippel, E Penner, et al.
Neurobiology of Aging|May 26, 2019
APOE effects on cognition from childhood to adolescenceChandra A Reynolds, Andrew Smolen, Robin P Corley, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
The Journal of Rheumatology|October 17, 2007
Association of anemia and physical disability among patients with rheumatoid arthritisChenglong Han, Mahboob U Rahman, Mittie K Doyle, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trialsM Boers, P Tugwell, D T Felson, et al.
Pageof 147